Your Guide to Drug Rehabilitation Statistics in New Jersey

Snapshot of Substance Use in New Jersey

The most recent statewide overview from the New Jersey Division of Mental Health and Addiction Services recorded 90,849 treatment admissions during calendar-year 2023, showing that roughly 9% of all adult New Jerseyans experienced formal substance-use care last year.[1]

Opioids remained the dominant driver, accounting for 44% of all primary admissions, followed by alcohol at 28%.[2] Stimulant admissions, primarily methamphetamine and prescription amphetamines, rose to 8%, nearly doubling since 2020.

These numbers generally follow national trends. A 2023 National Survey on Drug Use and Health estimated nearly 9% of all U.S. adults met the criteria for some degree of substance-use disorder in the same period.[3] New Jersey’s admission rate from opioids, specifically, however, is roughly 2% higher than the rest of the country.

Demographic Trends by Age & County

When it comes to an age-based breakdown, NJ adults between 35 and 54 show the largest group for New Jersey admissions at almost 40% of all admissions.[4] This is a shift from the historical concentration among twenty-somethings. Youth admissions (ages 12–17) held steady at 2%, but clinicians note rising concern about high-potency cannabis concentrates in this group as they become more prevalent.

At the county level, some of the biggest hotspots in the state for addiction treatment are Camden, Essex, and Middlesex. Together, these counties accounted for nearly one-third of all admissions, mirroring overdose-death clusters published by the CDC.[5]

Rural Cape May posted the highest per-capita alcohol-treatment rate, while opioid admissions in Ocean County continued to climb, driven by counterfeit oxycodone tablets laced with fentanyl. Hispanic residents represented 18% of statewide admissions, which is only slightly higher than their share of the state population, showing a clear need for culturally responsive outreach.[6]

These demographic details guide resource allocation, emphasizing medication-assisted detox beds in high-opioid counties and adolescent outpatient programs in communities where cannabis vaping is accelerating. By tracking localized trends alongside federal benchmarks, providers and policymakers can tailor evidence-based interventions that address New Jersey’s evolving substance-use landscape.

New Jersey Substance Abuse Treatment Admissions & Drug Rehabilitation Statistics

Primary Drug at Admission

Opioids are still the most common primary drugs across all areas, appearing on 44% of intake forms statewide, followed by alcohol at 28% and cannabis at 12%.[7] Stimulant admissions climbed to 8%, compared with 5% in 2021, indicating rapid growth in methamphetamine and prescription amphetamine misuse.

Cocaine, hallucinogens, and sedatives together comprised the remaining 8%. Among opioid clients, fentanyl was identified in roughly 73% of toxicology screens, far surpassing heroin detection, which has fallen below 20% for the first time since 2013.[8]

Levels of Care

Overall, out of the nearly 91,000 total admissions, 19% entered hospital-based or free-standing medical detox, 26% chose short-term residential rehab, and 31% enrolled in intensive outpatient programs that meet at least nine hours per week.[9] Standard outpatient care, defined as fewer than six clinical hours per week, accounted for 24% of the total.

Insurance and Payment Mix

Medicaid covers roughly a third of all treatment, while state contracts and county grants come in second place, funding about 19%.[10] Self-pay, veterans’ benefits, Medicare, and charity fill in the rest. Getting a gook look at client payment patterns can be a big help to providers when it comes to demand forecasting, negotiating insurer contracts, and securing grant money to close gaps in underserved counties and improve access to care.

A Look at New Jersey’s Drug & Alcohol Relapse and Long-Term Sobriety Statistics

Recovery is more than just getting through detox and passing a few drug tests successfully. True recovery is an ongoing, long-term effort, and one of the most important measurements of success is the one-year sobriety rate.

The New Jersey Substance Abuse Monitoring System conducted some interviews with individuals who were one year post-treatment. The results show that 54% of clients who completed at least ninety days of continuous treatment remained abstinent one year later, which is a massive improvement over the less than 30% of individuals who completed shorter treatment programs. National data from a 2023 SAMHSA Companion Report show a national one-year abstinence rate of 45%, indicating slightly stronger outcomes for programs within the state.[11]

Alcohol vs Opioid Relapse Rates

Alcohol clients who engaged in aftercare, which is defined as weekly counseling or support-group attendance for six months, ended up reporting a 29% relapse rate within twelve months. In contrast, opioid clients without medication assistance experienced a 43% relapse rate during the same period.[12] When buprenorphine, methadone, or extended-release naltrexone was added to therapy, opioid relapse fell to 25%, underscoring the importance of medication-assisted treatment for long-term stability.

Major Predictors of Sustained Recovery

Three variables consistently predict success across substances.

First, length of stay: clients who remain in structured care at least ninety days achieve nearly double the one-year sobriety rate of those who exit earlier.

Second, peer and family support: participation in Alcoholics Anonymous, SMART Recovery, or family-therapy sessions raises one-year abstinence rates substantially.

Third, integrated mental-health care: treating co-occurring disorders like depression or PTSD alongside addiction lowers emergency-department readmissions.

According to 2024 overdose death numbers, counties that expanded medication access and peer-recovery coaching saw a 9% decline in fatal opioid overdoses despite statewide fentanyl saturation, reinforcing the value of evidence-based practices and post-discharge monitoring.[13]

These outcome patterns show that New Jersey residents achieve higher long-term recovery when they invest in adequate treatment duration, add FDA-approved medications for opioid or alcohol use disorder, and stay connected to community support. Providers and policymakers can use these metrics to target resources toward interventions with the greatest proven impact on sustained sobriety.

4 Key Drivers of Success and SOBA NJ’s Response

#1 – Evidence-Based Therapies

Decades of research show that structured methods such as cognitive behavioral therapy, dialectical behavior therapy, acceptance and commitment therapy, and eye movement desensitization and reprocessing reduce substance cravings, improve mood regulation, and strengthen relapse-prevention skills. SOBA New Jersey integrates at least two of these modalities into every individual treatment plan. Clinicians use weekly progress scales to measure anxiety, depression, and drug urges so sessions can pivot toward the skills that deliver the greatest gains for each client.

#2 – Medication-Assisted Treatment

For opioid and alcohol use disorders, FDA-approved medications increase one-year abstinence chances. SOBA’s medical team offers buprenorphine, methadone, and extended-release naltrexone alongside counseling. Clients receive an individualized induction schedule, regular lab work to monitor liver and kidney markers, and monthly medication-management visits that adjust dosing as tolerance or life circumstances change. Education groups teach how these medications stabilize brain chemistry, allowing focus on therapy instead of withdrawal discomfort or obsessive craving.

#3 – Continuum of Care at SOBA NJ

Long-term recovery hinges on seamless transitions through detox, residential, partial hospitalization, intensive outpatient, and sober-living environments. SOBA maintains each level on a single campus or within nearby partner homes, removing transportation barriers that often disrupt care. Case managers coordinate with insurance carriers before every step-down so clients avoid surprise bills and coverage gaps. Alumni who completed the full continuum report a 30% lower relapse rate compared with those who left after residential treatment.

#4 – Nutrition, Adventure, and Family Programs

Holistic supports boost quality-of-life scores by filling the “empty hours” that often trigger relapse. SOBA’s nutritionists design meal plans that stabilize blood sugar levels, while certified trainers lead strength and cardio sessions that naturally elevate dopamine. Weekend adventure outings, such as fishing, kayaking, or hiking local trails and New Jersey state parks, teach the importance of sober fun and resilience. Parallel family workshops coach relatives on setting boundaries, effective communication techniques, and stress management.

Exit surveys indicate that clients whose families attend at least two workshops are twice as likely to stay engaged in aftercare as those without family participation. Through an expert combination of these drivers, SOBA New Jersey focuses its programs on specifically addressing the factors most strongly linked to long-term sobriety.

Getting Professional Addiction Treatment in New Jersey

While these addiction statistics might seem intimidating, even overwhelming at first, one thing is clear. With a statewide abstinence rate of more than 50%, more than half of all NJ residents who decide to get help stay clean for at least a year after completing at least 90 days of treatment.

That’s encouraging, and if you or someone you care about is struggling with drug abuse or drug-related stressors, getting help from SOBA New Jersey can get you the mental illness and addiction recovery help you need to live your best life.

Frequently Asked Questions About Treatment & Drug Rehabilitation Statistics in New Jersey